306 related articles for article (PubMed ID: 23683251)
1. Augmented anticancer activity of a targeted, intracellularly activatable, theranostic nanomedicine based on fluorescent and radiolabeled, methotrexate-folic Acid-multiwalled carbon nanotube conjugate.
Das M; Datir SR; Singh RP; Jain S
Mol Pharm; 2013 Jul; 10(7):2543-57. PubMed ID: 23683251
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronate tethered, "smart" multiwalled carbon nanotubes for tumor-targeted delivery of doxorubicin.
Datir SR; Das M; Singh RP; Jain S
Bioconjug Chem; 2012 Nov; 23(11):2201-13. PubMed ID: 23039830
[TBL] [Abstract][Full Text] [Related]
3. Targeting and inhibition of cell growth by an engineered dendritic nanodevice.
Thomas TP; Majoros IJ; Kotlyar A; Kukowska-Latallo JF; Bielinska A; Myc A; Baker JR
J Med Chem; 2005 Jun; 48(11):3729-35. PubMed ID: 15916424
[TBL] [Abstract][Full Text] [Related]
4. Drug targeting to arthritic region via folic acid appended surface-engineered multi-walled carbon nanotubes.
Kayat J; Mehra NK; Gajbhiye V; Jain NK
J Drug Target; 2016; 24(4):318-27. PubMed ID: 26289435
[TBL] [Abstract][Full Text] [Related]
5. Carbon nanotubes for delivery of small molecule drugs.
Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G
Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402
[TBL] [Abstract][Full Text] [Related]
6. Development, characterization and cancer targeting potential of surface engineered carbon nanotubes.
Mehra NK; Jain NK
J Drug Target; 2013 Sep; 21(8):745-58. PubMed ID: 23822734
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells.
Barar J; Kafil V; Majd MH; Barzegari A; Khani S; Johari-Ahar M; Asgari D; Coukos G; Omidi Y
J Nanobiotechnology; 2015 Mar; 13():26. PubMed ID: 25880772
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, pharmacoscintigraphic evaluation and antitumor efficacy of methotrexate-loaded, folate-conjugated, stealth albumin nanoparticles.
Jain S; Mathur R; Das M; Swarnakar NK; Mishra AK
Nanomedicine (Lond); 2011 Dec; 6(10):1733-54. PubMed ID: 22087800
[TBL] [Abstract][Full Text] [Related]
9. Intranuclear drug delivery and effective in vivo cancer therapy via estradiol-PEG-appended multiwalled carbon nanotubes.
Das M; Singh RP; Datir SR; Jain S
Mol Pharm; 2013 Sep; 10(9):3404-16. PubMed ID: 23905512
[TBL] [Abstract][Full Text] [Related]
10. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes.
Wen S; Liu H; Cai H; Shen M; Shi X
Adv Healthc Mater; 2013 Sep; 2(9):1267-76. PubMed ID: 23447549
[TBL] [Abstract][Full Text] [Related]
11. One platform comparison of estrone and folic acid anchored surface engineered MWCNTs for doxorubicin delivery.
Mehra NK; Jain NK
Mol Pharm; 2015 Feb; 12(2):630-43. PubMed ID: 25517904
[TBL] [Abstract][Full Text] [Related]
12. Arabinogalactan-folic acid-drug conjugate for targeted delivery and target-activated release of anticancer drugs to folate receptor-overexpressing cells.
Pinhassi RI; Assaraf YG; Farber S; Stark M; Ickowicz D; Drori S; Domb AJ; Livney YD
Biomacromolecules; 2010 Jan; 11(1):294-303. PubMed ID: 20014825
[TBL] [Abstract][Full Text] [Related]
13. Carbon nanotube lipid drug approach for targeted delivery of a chemotherapy drug in a human breast cancer xenograft animal model.
Shao W; Paul A; Zhao B; Lee C; Rodes L; Prakash S
Biomaterials; 2013 Dec; 34(38):10109-19. PubMed ID: 24060420
[TBL] [Abstract][Full Text] [Related]
14. Multimodal image-guided folic acid targeted Ag-based quantum dots for the combination of selective methotrexate delivery and photothermal therapy.
Hashemkhani M; Muti A; Sennaroğlu A; Yagci Acar H
J Photochem Photobiol B; 2020 Dec; 213():112082. PubMed ID: 33221627
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional dendrimer-modified multiwalled carbon nanotubes: synthesis, characterization, and in vitro cancer cell targeting and imaging.
Shi X; Wang SH; Shen M; Antwerp ME; Chen X; Li C; Petersen EJ; Huang Q; Weber WJ; Baker JR
Biomacromolecules; 2009 Jul; 10(7):1744-50. PubMed ID: 19459647
[TBL] [Abstract][Full Text] [Related]
16. A tumor-targeted, intracellular activatable and theranostic nanodiamond drug platform for strongly enhanced in vivo antitumor therapy.
Du X; Li L; Wei S; Wang S; Li Y
J Mater Chem B; 2020 Feb; 8(8):1660-1671. PubMed ID: 32011619
[TBL] [Abstract][Full Text] [Related]
17. Folic acid-modified methotrexate-conjugated gold nanoparticles as nano-sized trojans for drug delivery to folate receptor-positive cancer cells.
Yücel O; Şengelen A; Emik S; Önay-Uçar E; Arda N; Gürdağ G
Nanotechnology; 2020 Aug; 31(35):355101. PubMed ID: 32413875
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate-conjugated quantum dots: synthesis, characterisation and cytotoxicity in drug resistant cancer cells.
Johari-Ahar M; Barar J; Alizadeh AM; Davaran S; Omidi Y; Rashidi MR
J Drug Target; 2016; 24(2):120-33. PubMed ID: 26176269
[TBL] [Abstract][Full Text] [Related]
19. Specific targeting of cancer cells by multifunctional mitoxantrone-conjugated magnetic nanoparticles.
Heidari Majd M; Asgari D; Barar J; Valizadeh H; Kafil V; Coukos G; Omidi Y
J Drug Target; 2013 May; 21(4):328-40. PubMed ID: 23293842
[TBL] [Abstract][Full Text] [Related]
20. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
